scholarly journals Clinical Oncology Research and Reports (E-ISSN: 2693-4787) Dear Dr. Wilma D. Heemsbergen, Greetings! I am writing this email to introduce our Journal “Clinical Oncology Research and Reports” due for release our upcoming issue in the End of May. We have just gone through your published manuscript which was quite interesting “Breast-shape changes during radiation therapy after breast-conserving surgery” so we would like to publish your valuable manuscript in our Journal too. We believe that your research experience and abundance of knowledge will help us in spreading the scientific knowledge throughout the world, we request you to kindly submit your unpublished manuscript towards our esteemed Journal. Note: If you are interested in joining our Editorial/Reviewer Board please send your CV and a recent photograph We look forward to a long-lasting scientific relationship. Best Regards, Tracy Roy Editorial Coordinator Clinical Oncology Research and Reports Disclaimer: If you don’t want to wish to get emails from us please revert us with unsubscribe

2021 ◽  
Vol 7 (04) ◽  
pp. 01-08
Author(s):  
L. Atroune Atroune
Keyword(s):  
Clinical Oncology ◽  
Breast Conserving Surgery ◽  
Cutaneous Metastasis ◽  
Site Management ◽  
Research Experience ◽  
Unpublished Manuscript ◽  
Primary Glioblastoma ◽  
Oncology Research ◽  
Scalp Metastasis ◽  
Extracranial Metastases

Extracranial metastases from glioblastoma multiforme (GBM) are rare, especially cutaneous metastasis. However, the metastatic mechanism of GBM remains unknown with no current consensus regarding the best therapeutic regimen. We report the clinical, imaging and pathological features of a case of a 47 years old man with primary glioblastoma; who 12 months after receiving a macroscopically total resection and adjacent radiotherapy, developed scalp metastasis and subsequent multiple skin metastasis. We also discuss the details of this case in comparison with the previously reported cases in literature in terms of clinical presentation, lesions’ site, management and survival.

Streamlining Adverse Events Reporting in Oncology: An American Society of Clinical Oncology Research Statement

2018 ◽  
Vol 36 (6) ◽  
pp. 617-623 ◽  
Author(s):  
Laura A. Levit ◽  
Raymond P. Perez ◽  
David C. Smith ◽  
Richard L. Schilsky ◽  
Daniel F. Hayes ◽  
...  
Keyword(s):  
Adverse Events ◽  
Clinical Oncology ◽  
Oncology Research ◽  
American Society

scholarly journals Caregiver engagement practices in National Cancer Institute Clinical Oncology Research Program settings: Implications for research to advance the field

Cancer ◽  
2020 ◽  
Author(s):  
Chandylen L. Nightingale ◽  
Katherine R. Sterba ◽  
Laurie E. McLouth ◽  
Erin E. Kent ◽  
Emily V. Dressler ◽  
...  
Keyword(s):  
Clinical Oncology ◽  
Research Program ◽  
National Cancer Institute ◽  
Oncology Research

scholarly journals Scalp Metastasis as the First Sign of Small-Cell Lung Cancer: Management and Literature Review

2014 ◽  
Vol 99 (4) ◽  
pp. 325-329 ◽  
Author(s):  
Nikolaos S. Salemis ◽  
Georgios Veloudis ◽  
Kyriakos Spiliopoulos ◽  
Georgios Nakos ◽  
Nikolaos Vrizidis ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Cutaneous Metastasis ◽  
Small Cell ◽  
Clinical Entity ◽  
Small Cell Lung ◽  
Initial Manifestation ◽  
Cancer Management ◽  
Scalp Metastasis

Abstract Cutaneous metastasis from primary visceral malignancy is a relatively uncommon clinical entity, with a reported incidence ranging from 0.22% to 10% among various series. However, the presence of cutaneous metastasis as the first sign of a clinically silent visceral cancer is exceedingly rare. We describe here a case of an asymptomatic male patient who presented with a solitary scalp metastasis as the initial manifestation of an underlying small-cell lung cancer. Diagnostic evaluation revealed advanced disease. We conclude that the possibility of metastatic skin disease should always be considered in the differential diagnosis in patients with a history of smoking or lung cancer presenting with cutaneous nodules. Physicians should be aware of this rare clinical entity, and appropriate investigation should be arranged for early diagnosis and initiation of the appropriate treatment. The prognosis for most patients remains poor.

American Society of Clinical Oncology 2006 Update of the Breast Cancer Follow-Up and Management Guidelines in the Adjuvant Setting

2006 ◽  
Vol 24 (31) ◽  
pp. 5091-5097 ◽  
Author(s):  
James L. Khatcheressian ◽  
Antonio C. Wolff ◽  
Thomas J. Smith ◽  
Eva Grunfeld ◽  
Hyman B. Muss ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Physical Examination ◽  
Clinical Oncology ◽  
Cancer Recurrence ◽  
Breast Conserving Surgery ◽  
Adjuvant Setting ◽  
Positron Emission ◽  
American Society ◽  
Careful History

PurposeTo update the 1999 American Society of Clinical Oncology (ASCO) guideline on breast cancer follow-up and management in the adjuvant setting.MethodsAn ASCO Expert Panel reviewed pertinent information from the literature through March 2006. More weight was given to studies that tested a hypothesis directly relating testing to one of the primary outcomes in a randomized design.ResultsThe evidence supports regular history, physical examination, and mammography as the cornerstone of appropriate breast cancer follow-up. All patients should have a careful history and physical examination performed by a physician experienced in the surveillance of cancer patients and in breast examination. Examinations should be performed every 3 to 6 months for the first 3 years, every 6 to 12 months for years 4 and 5, and annually thereafter. For those who have undergone breast-conserving surgery, a post-treatment mammogram should be obtained 1 year after the initial mammogram and at least 6 months after completion of radiation therapy. Thereafter, unless otherwise indicated, a yearly mammographic evaluation should be performed. Patients at high risk for familial breast cancer syndromes should be referred for genetic counseling. The use of CBCs, chemistry panels, bone scans, chest radiographs, liver ultrasounds, computed tomography scans, [18F]fluorodeoxyglucose–positron emission tomography scanning, magnetic resonance imaging, or tumor markers (carcinoembryonic antigen, CA 15-3, and CA 27.29) is not recommended for routine breast cancer follow-up in an otherwise asymptomatic patient with no specific findings on clinical examination.ConclusionCareful history taking, physical examination, and regular mammography are recommended for appropriate detection of breast cancer recurrence.

scholarly journals Need for Global Partnership in Cancer Care: Perceptions of Cancer Care Researchers Attending the 2010 Australia and Asia Pacific Clinical Oncology Research Development Workshop

2011 ◽  
Vol 7 (5) ◽  
pp. 324-329 ◽  
Author(s):  
H. Kim Lyerly ◽  
Amy P. Abernethy ◽  
Martin R. Stockler ◽  
Bogda Koczwara ◽  
Zeba Aziz ◽  
...  
Keyword(s):  
Cancer Research ◽  
Developing Country ◽  
Clinical Oncology ◽  
Cancer Care ◽  
Asia Pacific ◽  
Research Development ◽  
Global Partnership ◽  
Oncology Research

Cancer research globally faces significant barriers, many of which are magnified in the developing country setting.

scholarly journals Endometrial carcinoma metastatic to the scalp

2021 ◽  
Vol 54 (2) ◽  
Author(s):  
Joana Aidos ◽  
Sónia Gonçalves ◽  
Teresa Carvalho ◽  
Nuno Nogueira Martins ◽  
Francisco Nogueira Martins
Keyword(s):  
Endometrial Carcinoma ◽  
Endometrial Adenocarcinoma ◽  
Cutaneous Metastasis ◽  
Scalp Metastasis ◽  
Widespread Dissemination

Endometrial carcinoma is a very rare cause of cutaneous metastasis. The most frequent presentations of cutaneous metastasis are fast developing nodules or tumors, which are evidence of widespread dissemination in such patients. We report a case of scalp metastasis from an endometrial adenocarcinoma with a fatal prognosis.  

Sign in / Sign up

Export Citation Format

Share Document